138 related articles for article (PubMed ID: 18223465)
1. Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgery.
Macdonald I; Staatz CE; Jelliffe RW; Thomson AH
Ther Drug Monit; 2008 Feb; 30(1):67-74. PubMed ID: 18223465
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
Staatz CE; Byrne C; Thomson AH
Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
White LO; Holt HA; Reeves DS; MacGowan AP
J Antimicrob Chemother; 1997 Mar; 39(3):355-61. PubMed ID: 9096185
[TBL] [Abstract][Full Text] [Related]
4. To Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models.
Goutelle S; Alloux C; Bourguignon L; Van Guilder M; Neely M; Maire P
Ther Drug Monit; 2021 Aug; 43(4):461-471. PubMed ID: 34250963
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian approach to tracking patients having changing pharmacokinetic parameters.
Bayard DS; Jelliffe RW
J Pharmacokinet Pharmacodyn; 2004 Feb; 31(1):75-107. PubMed ID: 15346853
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Bayesian predictability of vancomycin concentration in patients with various degrees of renal function.
Ohnishi A; Yano Y; Shimamura K; Oguma T
Biol Pharm Bull; 2001 Dec; 24(12):1446-50. PubMed ID: 11767122
[TBL] [Abstract][Full Text] [Related]
8. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin monitoring: one or two serum levels?
Andrés I; López R; Pou L; Piñol F; Pascual C
Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
[TBL] [Abstract][Full Text] [Related]
10. A clinical decision support system to improve adequate dosing of gentamicin and vancomycin.
Pereboom M; Mulder IJ; Verweij SL; van der Hoeven RTM; Becker ML
Int J Med Inform; 2019 Apr; 124():1-5. PubMed ID: 30784421
[TBL] [Abstract][Full Text] [Related]
11. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
[TBL] [Abstract][Full Text] [Related]
14. Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis.
Brophy DF; Sowinski KM; Kraus MA; Moe SM; Klaunig JE; Mueller BA
Perit Dial Int; 1999; 19(6):534-9. PubMed ID: 10641773
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.
Kisor DF; Watling SM; Zarowitz BJ; Jelliffe RW
Clin Pharmacokinet; 1992 Jul; 23(1):62-8. PubMed ID: 1617859
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
Neef C; Touw DJ; Harteveld AR; Eerland JJ; Uges DR
Ther Drug Monit; 2006 Oct; 28(5):686-9. PubMed ID: 17038886
[TBL] [Abstract][Full Text] [Related]
19. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Pea F; Porreca L; Baraldo M; Furlanut M
J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
[TBL] [Abstract][Full Text] [Related]
20. [A priori prediction of gentamicin peak concentrations: Use of a simple and practical tool].
Mignaval F; Fontaine PA; Riché A; Nowak C; Cancel D; Lemaitre F
Pathol Biol (Paris); 2011 Apr; 59(2):79-82. PubMed ID: 20822863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
